Tender detail
Non-exclusive rebate agreement for medicines containing cladribine for 1 December 2026 to 30 November 2027
Summary
DAK-Gesundheit intends to conclude a non-exclusive rebate agreement for medicines containing cladribine (ATC L04AA40). The agreement will run from 1 December 2026 to 30 November 2027 and may be extended once for 12 months. It will end automatically when an exclusive agreement takes effect.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.